New Results
Site-specific analysis of the SARS-CoV-2 glycan shield
View ORCID ProfileYasunori Watanabe, View ORCID ProfileJoel D. Allen, Daniel Wrapp, Jason S. McLellan, View ORCID ProfileMax Crispin
doi: https://doi.org/10.1101/2020.03.26.010322
Yasunori Watanabe
1School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK
2Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK
3Division of Structural Biology, University of Oxford, Wellcome Centre for Human Genetics, Oxford, OX3 7BN, UK
Joel D. Allen
1School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK
Daniel Wrapp
4Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA
Jason S. McLellan
4Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA
Max Crispin
1School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK
Posted March 28, 2020.
Site-specific analysis of the SARS-CoV-2 glycan shield
Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin
bioRxiv 2020.03.26.010322; doi: https://doi.org/10.1101/2020.03.26.010322
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)